(EPZM:Consolidated Issue Listed on NASDAQ Global Select )
Eric E. Hedrick M.D.
Former Chief Medical Officer, Epizyme, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2013
Dr. Eric E. Hedrick, M.D. served as the Chief Medical Officer of Epizyme, Inc. from May 2012 to October 31, 2014. Dr. Hedrick served as an Interim Chief Medical Officer of Pharmacyclics Inc. since May 2011 and served as its Vice President of Oncology Development from August 2010 to April 2012. From October 2009 to August 2010, Dr. Hedrick was an independent drug development consultant, including consulting with Pharmacyclics on the development of PCI-32765. From November ...
400 Technology SquarePhone: 617-229-5872
Cambridge, Massachusetts 02139
Board Members Memberships*There is no Board Members Memberships data available.
University of Maryland School of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jean-Jacques Bienaime MBA||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Jean-Paul Clozel M.D.||Founder, Chief Executive Officer, Member of Management Board and Director|
|David L. Hallal||Chief Executive Officer and Director|
Alexion Pharmaceuticals, Inc.
|Jan G. J. van de Winkel Ph.D.||Co-Founder, Chief Executive Officer and President|
|kr11.0M||Compensation as of Fiscal Year 2014.|